Legal Issues Surrounding Biometric Patent Databases And Health Privacy Rights.
⚖️ Legal Issues in Biometric Patent Databases and Health Privacy
Biometric databases (fingerprints, retinal scans, facial recognition) combined with health information raise complex legal questions because they involve:
- Patentability of biometric algorithms and medical technologies
- Ownership of inventions derived from biometric data
- Privacy and consent under health laws
- Data security obligations for sensitive health information
- Regulation of secondary use and commercialization of biometric data
⚖️ 1. Moore v. Regents of the University of California, 51 Cal.3d 120 (1990)
Facts
- John Moore’s spleen cells were used to develop a lucrative cell line without his consent.
- Moore sued for ownership of the cell line and profits.
Outcome
- Court ruled individuals do not have property rights over excised cells or biological derivatives, but physicians must obtain informed consent.
Relevance
- Biometric databases and medical data used for patents must respect consent and privacy, but individuals may not automatically own resulting IP.
Implication
- Health systems collecting biometric data for innovation must clarify ownership and consent agreements.
⚖️ 2. Association for Molecular Pathology v. Myriad Genetics, 569 U.S. 576 (2013)
Facts
- Myriad Genetics claimed patents on isolated BRCA1/BRCA2 genes used for cancer testing.
Outcome
- Supreme Court held naturally occurring DNA cannot be patented, but synthetic DNA (cDNA) is patentable.
Relevance
- Algorithms analyzing biometric and health data may be patentable if sufficiently human-created and novel, but raw biological information cannot be claimed as IP.
Implication
- Biometric algorithms for disease prediction or health risk assessment must focus on novel computational methods, not raw data.
⚖️ 3. Mayo Collaborative Services v. Prometheus Laboratories, 566 U.S. 66 (2012)
Facts
- Patents claimed a method for optimizing drug dosage based on metabolite levels.
Outcome
- Supreme Court ruled laws of nature, natural correlations, and abstract ideas are not patentable, unless inventive application exists.
Relevance
- Algorithms linking biometric signals to health conditions may face patent challenges if they merely recite a natural correlation.
Implication
- Patents for UHI or health biometric applications must demonstrate specific technological steps beyond natural relationships.
⚖️ 4. Gruber v. GitHub / AI Inventorship Cases (Conceptual Analogy)
Facts
- AI-generated code or inventions cannot be listed as inventors in patents (DABUS/Thaler cases).
Relevance
- AI-generated biometric analysis tools cannot claim AI as inventor; human researchers must be designated.
Implication
- Ownership of AI-created health risk prediction algorithms must be contractually assigned to developers or institutions.
⚖️ 5. In re Application of Myriad / European Biometric Database Guidelines
Facts
- European Patent Office allows patents for software and algorithms only if they show technical effect.
Relevance
- Biometric pattern recognition or health prediction algorithms are patentable if integrated with hardware or producing a technical solution.
Implication
- Simple statistical correlation between fingerprints and disease risk may not be patentable; must integrate into a technical system (e.g., scanning device or medical instrument).
⚖️ 6. Carpenter v. United States, 585 U.S. ___ (2018)
Facts
- The Supreme Court ruled that accessing historical cell-site location data constitutes a search under the Fourth Amendment, requiring legal process.
Relevance
- Health or biometric databases must respect privacy protections, even in research.
- Unauthorized access or sharing of patient biometric data may constitute legal violation.
⚖️ 7. GDPR and Schrems II (EU Context)
Facts
- European Court of Justice invalidated the Privacy Shield, emphasizing cross-border transfer of personal data requires strict protection.
Relevance
- Biometric databases containing health data may face international transfer restrictions.
- Researchers must ensure data anonymization or consent-based processing.
⚖️ 8. Health Privacy Litigation Examples: Sorrell v. IMS Health (2011)
Facts
- Use of prescriber data for marketing purposes challenged as a privacy violation.
Relevance
- Secondary use of biometric health data (for patents, analytics, or commercialization) may raise privacy and consent challenges, even if anonymized.
⚖️ Key Legal Issues and Takeaways
| Legal Issue | Explanation | Case Law Reference |
|---|---|---|
| Human Inventorship | AI cannot be listed as inventor; humans must be named | Thaler v. Hirshfeld, Gruber analogy |
| Patent Eligibility | Natural data, correlations, or raw biometrics are not patentable; synthetic or technical applications are | Myriad Genetics, Mayo v. Prometheus |
| Data Ownership | Individuals typically do not own extracted biological data, but consent is required | Moore v. Regents |
| Privacy and Access | Unauthorized access to health data constitutes legal violation | Carpenter v. US, Sorrell v. IMS Health |
| Cross-border Data | GDPR and Schrems II restrict transfer and processing | Schrems II, EU data guidance |
| Trade Secrets | AI-created analysis pipelines may be protected via trade secrets | DuPont v. Kolon analogy |
| Liability | Misuse or breach of health data can trigger civil and criminal liability | HIPAA analogies, GDPR fines |
🔑 Practical Implications for Biometric Patent Databases
- Ensure human inventorship for AI-generated algorithms used in health analytics.
- Patent only technical applications, not raw biometric patterns or natural correlations.
- Obtain informed consent from individuals whose biometric data is stored or analyzed.
- Use trade secrets for proprietary algorithms or processing pipelines to protect IP while maintaining privacy.
- Comply with privacy and data transfer regulations, especially cross-border.
- Establish liability frameworks for unauthorized access, misuse, or AI errors in health analytics.
RELATED Blog
comments